Lewis, S., Vredenburgh, J., Desjardins, A., Peters, K., Green, S., Hood, R., … Kirkpatrick, J. P. (2012). Patterns of Failure as a Function of Clinical Target Volumes in Patients With GBM Treated With Radiation Therapy (RT), Temozolomide, and Bevacizumab. In International Journal of Radiation Oncology*Biology*Physics (Vol. 84, pp. S266–S267). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2012.07.694

Lewis, S., J. Vredenburgh, A. Desjardins, K. Peters, S. Green, R. Hood, Y. Yang, J. Sampson, Z. Wang, and J. P. Kirkpatrick. “Patterns of Failure as a Function of Clinical Target Volumes in Patients With GBM Treated With Radiation Therapy (RT), Temozolomide, and Bevacizumab.” In International Journal of Radiation Oncology*Biology*Physics, 84:S266–67. Elsevier BV, 2012. https://doi.org/10.1016/j.ijrobp.2012.07.694.

Lewis S, Vredenburgh J, Desjardins A, Peters K, Green S, Hood R, et al. Patterns of Failure as a Function of Clinical Target Volumes in Patients With GBM Treated With Radiation Therapy (RT), Temozolomide, and Bevacizumab. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012. p. S266–7.

Lewis, S., et al. “Patterns of Failure as a Function of Clinical Target Volumes in Patients With GBM Treated With Radiation Therapy (RT), Temozolomide, and Bevacizumab.” International Journal of Radiation Oncology*Biology*Physics, vol. 84, no. 3, Elsevier BV, 2012, pp. S266–67. Crossref, doi:10.1016/j.ijrobp.2012.07.694.

Lewis S, Vredenburgh J, Desjardins A, Peters K, Green S, Hood R, Yang Y, Sampson J, Wang Z, Kirkpatrick JP. Patterns of Failure as a Function of Clinical Target Volumes in Patients With GBM Treated With Radiation Therapy (RT), Temozolomide, and Bevacizumab. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012. p. S266–S267.